A subscription to JoVE is required to view this content. Sign in or start your free trial.
Transthoracic ultrasound-guided lung biopsy represents a safe, cost-effective, and efficient approach for patients presenting with subpleural lung lesions suspected of malignancy. Employing a systematic, step-by-step process is crucial to achieve optimal patient selection, minimize complication risks, and maximize diagnostic accuracy.
Diagnosing patients with radiological lung lesions, especially those suspected of having primary lung cancer, is a common and critical clinical scenario. When selecting the most suitable invasive procedure to establish a diagnosis in these cases, a delicate balance must be struck between achieving a high diagnostic yield, providing staging information, minimizing potential complications, enhancing the patient experience, and controlling costs. The integration of thoracic ultrasound as a routine clinical tool in respiratory medicine has led to increased awareness and utilization of ultrasound-guided invasive techniques in chest procedures, including transthoracic biopsies. By following a systematic and stepwise approach, transthoracic ultrasound-guided lung biopsy emerges as a safe, cost-effective procedure with a remarkable diagnostic accuracy. These attributes collectively position it as an ideal invasive technique when technically feasible. Consequently, in patients presenting subpleural lung lesions suspected of malignancy, transthoracic ultrasound-guided lung biopsy has become a standard procedure in the realm of modern invasive pulmonology.
Establishing a diagnosis in patients with radiological lung lesions is crucial, particularly when malignancy is suspected. Tissue sampling is essential for confirming malignancy, obtaining additional information like genotyping and staging, and diagnosing non-malignant lung lesions (e.g., infection or vasculitis)1,2.
Several invasive procedures are available for tissue sampling in patients with lung lesions, including conventional bronchoscopy, bronchoscopy supplemented with radial endobronchial ultrasound (REBUS), electromagnetic navigation bronchoscopy (ENB), endobronchial ultraso....
The described protocol below follows the human care guidelines of Odense University Hospital, Odense, Denmark, and the University of Southern Denmark, Odense, Denmark. The step-wise protocol described below represents a potential, systematic approach for a typical patient with suspected lung cancer for whom US-TTNB was performed in an outpatient or daycase setting. Informed written consent was obtained from the patient. We have taken into account current clinical practices at the authors' institutions, as well as des.......
The overall diagnostic yield of US-TTNB in patients with lung lesions has been reported as 88.7% in a meta-analysis by DiBardiono et al.18. However, it should be noted that other studies have reported lower diagnostic yields of US-TTNB17,23,25. Several patient factors have been shown to affect the diagnostic yield of US-TTNB, including: (1) whether there is a malignant or non-malignant condition; (2) the .......
Appropriate patient selection and a careful initial TUS assessment are crucial steps before performing US-TTNB. If the lung lesion cannot be visualized, US-TTNB is not a viable option. Ideally, TUS should be conducted before scheduling the procedure during the clinic visit to prevent last-minute cancellations in the procedural room17. This approach also allows for more comprehensive planning and a potential shift to an alternative invasive procedure if the lesion cannot be visualized
None.
....Name | Company | Catalog Number | Comments |
Ambu BlueSensor R | Ambu | R-00-S/25 | ECG patches |
BD Nexiva Closed IV Catheter System (20 GA x 1.25 in)(1.1 x 32 mm) | BD | 383667 | Intravenous accesskit |
BD PosiFlush SP Syringe 5 mL | BD | 306574 | Syringe with 5 mL 0.9% NaCl |
Blunt Fill Needle with 5 Micron Filter (18 G x 11/2") | Sol-Millennium Medical Inc. | BN1815F | 18 G needle |
C1-6VN ultrasound transducer | GE Healthcare | 5476279 | Ultrasound transducer |
C2-9D ultrasound transducer | GE Healthcare | 5405253 | Ultrasound transducer |
CARBON STEEL SURGICAL BLADES | Swann-Morton | 203 | Scalpel blade |
Disinfection wipe (82% ehanol + 0.5% chlorhexidine) | Vitrex Medical A/S | 527297 | Disinfection wipe |
Disposable needle single use (0.80 mm x 80 mm) | Misawa Medical Industry Co., Ltd. | K070001 | 80 mm 21 G hypodermic needle |
EKO GEL | Ekkomed A/S | 29060008-29 | Ultrasound gel |
Formalin system, buffered formalin solution 450 mL | Sarstedt | 5,11,703 | Biopsy specimen contained and relevant fixation liquid (e.g. formaldehyde) |
GAMMEX Latex | Ansell | 330048075 | Sterile gloves |
KD-JECT 20 mL | KD Medcial GmbH | 820209 | 20 mL syringe |
Klorhexidin sprit 0.5% 500 mL | Fuckborg Pharma | 212045 | Disinfectant |
Lidokain Mylan 10 mg/mL, 20 mL | Mylan | NO-6042A1 | Local anesthetic (20 mL, 2% lidocaine) |
LOGIQ E10 | GE Healthcare | NA | High-end ultrasound machine |
Mölnlycke BARRIER Adhesive Aperture Drape (50 x 60 cm / 6 x 8 cm) | Mölnlycke Healthcare AB | 906693 | Adhesive surgical drape with a central hole |
Mölnlycke Gauze 10 x 10 cm | Mölnlycke Healthcare AB | 158440 | Swaps for applying disinfectant |
Philips IntelliVue X2 | Philips | NA | Patient monitoring system |
Raucodrape PRO 75 x 90 cm | Lohmann & Rauscher International GmbH & Co | 33 005 | Sterile drape for procedure table |
SEMICUT 18 G x 100 mm | MDL | PD01810 | 18 G x 100 mm core biopsy needle |
SEMICUT 18 G x 160 mm | MDL | PD01816 | 18 G x 160 mm core biopsy needle |
S-Monovette, 25 mL, for Formalin system, (LxØ): 97 x 25 mm, with paper label | Sarstedt | 9,17,05,001 | Biopsy specimen container |
Sterican (0.80 x 120 mm BL/LB) | Braun | 4665643 | 120 mm 21 G hypodermic needle |
Tegaderm I.V. | 3M | 1633 | I.V. Transparent film dressing with border |
Ultra-Pro IIÂ Disposable Replacement Kits | CIVCO | 610-608 | For use with GE Healthcare C2-9 transducer |
Ultra-Pro IIÂ In-Plane Ultrasound Needle Guides-Multi-Angle | CIVCO | H4913BA | For use with GE Healthcare C2-9 transducer |
Verza Needle Guidance System for VerzaLink™ Transducers | CIVCO | 610-1500-24 | For use with GE Healthcare C1-6 transducer |
Verza Ultrasound Needle Guidance System | CIVCO | H4917VB | For use with GE Healthcare C1-6 transducer |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved